Clinical Trials Browser

Phase 1 × Advanced Solid Tumor × Breast × Clear all

NCT05076591 2024-10-30

IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors

Phase 1 Suspended

BreastGastrointestinalOther solid neoplasm

Advanced Solid Tumor